Delcath Systems
Yahoo Finance • 3 years ago
Delcath Systems Reports First Quarter 2022 Results and Provides Business Update
NEW YORK , May 10, 2022 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, today reported business highlights and financia... Full story
Yahoo Finance • 3 years ago
Delcath Systems to Participate in the Canaccord Genuity Horizons in Oncology Conference
NEW YORK, April 08, 2022 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, will participate in the Canaccord Genuity Hori... Full story
Yahoo Finance • 3 years ago
Delcath Systems to Participate in the Lytham Partners Spring 2022 Investor Conference
NEW YORK, March 29, 2022 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, announced today that it will be participating... Full story
Yahoo Finance • 3 years ago
Delcath Systems Reports Fourth Quarter and Full-Year 2021 Results and Provides Business Update
NEW YORK, March 25, 2022 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, today reported business highlights and financi... Full story
